<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00999297</url>
  </required_header>
  <id_info>
    <org_study_id>PBRC 28016</org_study_id>
    <secondary_id>PBRC28016</secondary_id>
    <nct_id>NCT00999297</nct_id>
  </id_info>
  <brief_title>Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate</brief_title>
  <acronym>CAPSPAL</acronym>
  <official_title>Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate: A Double-blind Randomized Parallel Arm Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pennington Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ajinomoto USA, INC.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Pennington Biomedical Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A 4 week intake of drug to find a natural substance that may modify energy balance and may
      enhance health in combination with lifestyle changes with possible decrease in body weight.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a double-blind, placebo-controlled, single center, randomized, parallel arm
      clinical trial to test the impact of Dihydrocapsiate (placebo, 3 and 9 mg/d) ingested for 4
      weeks on resting metabolic rate and fat oxidation measured by indirect calorimetry.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The consumption of dihydrocapsiate will significantly increase resting energy expenditure and fat oxidation</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">79</enrollment>
  <condition>Obesity</condition>
  <condition>Weight</condition>
  <arm_group>
    <arm_group_label>Sugar pill (Placebo o mg/d)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0 mg/d sugar pill</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dihydrocapsiate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug 3 mg/d or 9 mg/d including Placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 mg/d or 9 mg/d Dihydrocapsiate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug including Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dihydrocapsiate</intervention_name>
    <description>Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo</description>
    <arm_group_label>Sugar pill (Placebo o mg/d)</arm_group_label>
    <other_name>Natural Substances present in chili pepper</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dihydrocapsiate</intervention_name>
    <description>Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo</description>
    <arm_group_label>Dihydrocapsiate</arm_group_label>
    <other_name>Natural Substances present in chili pepper</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dihydrocapsiate</intervention_name>
    <description>Capsules will contain dihydrocapsiate 3 mg/d or 9 mg/d or placebo</description>
    <arm_group_label>3 mg/d or 9 mg/d Dihydrocapsiate</arm_group_label>
    <other_name>Natural Substances present in chili pepper</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men between 20-60 years old

          -  Healthy as assessed by medical history and standard medical exam

          -  Weight-stable

          -  Body mass index of 25 to 34.9 kg/m2

          -  Non-smoker

          -  Sedentary lifestyle: not being physically active grater than 3 days/week for 20 min
             each time for the previous 6 months, and not participating in regular resistance
             exercise.

        Exclusion Criteria:

          -  Subjects enrolled in a diet to increase or decrease body weight

          -  Special diet or food aversiions to common foods

          -  Has allergy to chilli pepper

          -  Eating chilli peppers on a daily basis

          -  Usually consuming more than 2 cups of tea or coffee/day

          -  Usually consuming more than 4 cans of caffeinated soft drinks a day

          -  Usually consuming more than 3 standard alcohol drinks/day

          -  Regular use of medications (weight loss drugs, drugs affecting energy metabolism,
             drugs for depression)

          -  Usual intake of illicit substances

          -  Claustrophobia

          -  Participating or having participated in another clinical trial during the last 4 weeks
             prior to the beginning of this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Ravussin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennington Biomedical Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pennington Biomedical Research Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70809</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://ajcn.nutrition.org/content/92/5/1089.long</url>
    <description>Effect of dihydrocapsiate on resting metabolic rate in humans.</description>
  </link>
  <link>
    <url>http://journals.cambridge.org/download.php?file=%2FBJN%2FBJN103_01%2FS0007114509991358a.pdf&amp;code=1af15165e3c2df5c00062d1042e9273c</url>
    <description>Effect of capsinoids on energy metabolism in human subjects</description>
  </link>
  <results_reference>
    <citation>Galgani JE, Ryan DH, Ravussin E. Effect of capsinoids on energy metabolism in human subjects. Br J Nutr. 2010 Jan;103(1):38-42. doi: 10.1017/S0007114509991358. Epub 2009 Aug 12.</citation>
    <PMID>19671203</PMID>
  </results_reference>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2009</study_first_submitted>
  <study_first_submitted_qc>October 20, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2009</study_first_posted>
  <last_update_submitted>November 18, 2015</last_update_submitted>
  <last_update_submitted_qc>November 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pennington Biomedical Research Center</investigator_affiliation>
    <investigator_full_name>Eric Ravussin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>thermogenesis</keyword>
  <keyword>respiratory quotient</keyword>
  <keyword>fat oxidation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Capsaicin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

